Starpharma Holdings Ltd
PQ6
Company Profile
Business description
Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating, and VIRALEZE, an antiviral nasal spray.
Contact
4-6 Southampton Crescent
Abbotsford
MelbourneVIC3067
AUST: +61 385322700
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
Employees
32
Stocks News & Analysis
stocks
Tesla: Shares fall as market disappointed with Cybercab launch event
We think Tesla stock is fairly valued.
stocks
The best global tech stocks to buy
These 12 undervalued technology stocks look attractive today.
stocks
Earnings margins to improve for mining specialist
Premium products drive margins yet shares fully valued.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,102.90 | 15.70 | -0.17% |
| CAC 40 | 8,156.67 | 161.31 | -1.94% |
| DAX 40 | 25,576.45 | 431.18 | -1.66% |
| Dow JONES (US) | 52,505.65 | 280.42 | -0.53% |
| FTSE 100 | 10,670.06 | 141.60 | -1.31% |
| HKSE | 25,274.96 | 42.22 | -0.17% |
| NASDAQ | 26,268.71 | 152.70 | -0.58% |
| Nikkei 225 | 65,142.78 | 126.55 | -0.19% |
| NZX 50 Index | 13,819.43 | 26.53 | 0.19% |
| S&P 500 | 7,645.16 | 28.36 | -0.37% |
| S&P/ASX 200 | 8,911.40 | 16.20 | -0.18% |
| SSE Composite Index | 3,951.51 | 10.96 | 0.28% |